Anixa Biosciences, Inc.
ANIX
$2.77
$0.000.00%
NASDAQ
| 01/31/2026 | 10/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -6.92% | 25.56% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.56% | 18.06% | |||
| Operating Income | 5.56% | -18.06% | |||
| Income Before Tax | 5.03% | -19.39% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 5.03% | -19.39% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -25.93% | 22.73% | |||
| Net Income | 4.82% | -19.35% | |||
| EBIT | 5.56% | -18.06% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 5.62% | -17.70% | |||
| Normalized Basic EPS | 5.51% | -17.59% | |||
| EPS Diluted | 5.62% | -17.70% | |||
| Normalized Diluted EPS | 5.51% | -17.59% | |||
| Average Basic Shares Outstanding | 0.92% | 1.42% | |||
| Average Diluted Shares Outstanding | 0.92% | 1.42% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||